{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T19:23:23Z","timestamp":1787426603532,"version":"build-2736575974"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40291-026-00861-6","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:44:43Z","timestamp":1781192683000},"page":"721-738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LINE-1 Deregulation in Ovarian Cancer: Implications for Diagnosis, Prognosis, and Therapeutic Targeting"],"prefix":"10.1007","volume":"30","author":[{"given":"Nicoletta","family":"Bonci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Schiavoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesmina","family":"Rexha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Romagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Campagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7003-1230","authenticated-orcid":false,"given":"Giovanni","family":"Tossetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"861_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/IJWH.S197604","volume":"11","author":"Z Momenimovahed","year":"2019","unstructured":"Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019;11:287\u201399. https:\/\/doi.org\/10.2147\/IJWH.S197604.","journal-title":"Int J Womens Health."},{"key":"861_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108930","author":"G Tossetta","year":"2023","unstructured":"Tossetta G, Inversetti A. Ovarian cancer: advances in pathophysiology and therapies. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24108930.","journal-title":"Int J Mol Sci"},{"key":"861_CR3","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.2147\/IJWH.S473381","volume":"16","author":"K Hong","year":"2024","unstructured":"Hong K, Liu Y, Yin H, Huang K, Pu XL, Zhu ZX. Identifying factors contributing to delayed diagnosis of ovarian cancer: a comprehensive analysis. Int J Womens Health. 2024;16:1463\u201373. https:\/\/doi.org\/10.2147\/IJWH.S473381.","journal-title":"Int J Womens Health."},{"key":"861_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"},{"key":"861_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.974536","volume":"9","author":"Y Wang","year":"2022","unstructured":"Wang Y, Shan X, Dong H, Li M, Yue Y. Prediction for 2-year mortality of metastatic ovarian cancer patients based on surveillance, epidemiology, and end results database. Front Surg. 2022;9:974536. https:\/\/doi.org\/10.3389\/fsurg.2022.974536.","journal-title":"Front Surg."},{"key":"861_CR6","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3904\/kjim.2017.008","volume":"32","author":"JY Kim","year":"2017","unstructured":"Kim JY, Cho CH, Song HS. Targeted therapy of ovarian cancer including immune check point inhibitor. Korean J Intern Med. 2017;32:798\u2013804. https:\/\/doi.org\/10.3904\/kjim.2017.008.","journal-title":"Korean J Intern Med"},{"key":"861_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jox16010009","author":"M Cecati","year":"2026","unstructured":"Cecati M, Pozzi V, Pompei V, Schiavoni V, Fumarola S, Romagnoli A, et al. Cisplatin as a xenobiotic agent: molecular mechanisms of actions and clinical applications in oncology. J Xenobiot. 2026. https:\/\/doi.org\/10.3390\/jox16010009.","journal-title":"J Xenobiot."},{"key":"861_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112893","author":"G Tossetta","year":"2022","unstructured":"Tossetta G. Metformin improves ovarian cancer sensitivity to paclitaxel and platinum-based drugs: a review of in vitro findings. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232112893.","journal-title":"Int J Mol Sci"},{"key":"861_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062773","author":"K De","year":"2025","unstructured":"De K, Jana M, Chowdhury B, Calaf GM, Roy D. Role of PARP inhibitors: a new hope for breast cancer therapy. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26062773.","journal-title":"Int J Mol Sci"},{"key":"861_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1158\/0008-5472.CAN-15-1382","volume":"76","author":"R Perets","year":"2016","unstructured":"Perets R, Drapkin R. It\u2019s totally tubular\u2026.riding the new wave of ovarian cancer research. Cancer Res. 2016;76:10\u20137. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1382.","journal-title":"Cancer Res"},{"key":"861_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","volume":"186","author":"RJ Kurman","year":"2016","unstructured":"Kurman RJ, Shih IM. The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded. Am J Pathol. 2016;186:733\u201347. https:\/\/doi.org\/10.1016\/j.ajpath.2015.11.011.","journal-title":"Am J Pathol"},{"key":"861_CR12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg1655","volume":"6","author":"KD Robertson","year":"2005","unstructured":"Robertson KD. DNA methylation and human disease. Nat Rev Genet. 2005;6:597\u2013610. https:\/\/doi.org\/10.1038\/nrg1655.","journal-title":"Nat Rev Genet"},{"key":"861_CR13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg816","volume":"3","author":"PA Jones","year":"2002","unstructured":"Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415\u201328. https:\/\/doi.org\/10.1038\/nrg816.","journal-title":"Nat Rev Genet"},{"key":"861_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2018.08.001","volume":"204","author":"L Morales-Nebreda","year":"2019","unstructured":"Morales-Nebreda L, McLafferty FS, Singer BD. DNA methylation as a transcriptional regulator of the immune system. Transl Res. 2019;204:1\u201318. https:\/\/doi.org\/10.1016\/j.trsl.2018.08.001.","journal-title":"Transl Res"},{"key":"861_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2217\/epi.09.33","volume":"1","author":"M Ehrlich","year":"2009","unstructured":"Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics. 2009;1:239\u201359. https:\/\/doi.org\/10.2217\/epi.09.33.","journal-title":"Epigenomics"},{"key":"861_CR16","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","volume":"128","author":"PA Jones","year":"2007","unstructured":"Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128:683\u201392. https:\/\/doi.org\/10.1016\/j.cell.2007.01.029.","journal-title":"Cell"},{"key":"861_CR17","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nrc3130","volume":"11","author":"SB Baylin","year":"2011","unstructured":"Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011;11:726\u201334. https:\/\/doi.org\/10.1038\/nrc3130.","journal-title":"Nat Rev Cancer"},{"key":"861_CR18","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra072067","volume":"358","author":"M Esteller","year":"2008","unstructured":"Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358:1148\u201359. https:\/\/doi.org\/10.1056\/NEJMra072067.","journal-title":"N Engl J Med"},{"key":"861_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023332","volume":"6","author":"F Ohka","year":"2011","unstructured":"Ohka F, Natsume A, Motomura K, Kishida Y, Kondo Y, Abe T, et al. The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma. PLoS ONE. 2011;6:e23332. https:\/\/doi.org\/10.1371\/journal.pone.0023332.","journal-title":"PLoS ONE"},{"key":"861_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13148-023-01440-w","volume":"15","author":"SK Terp","year":"2023","unstructured":"Terp SK, Stoico MP, Dybkaer K, Pedersen IS. Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review. Clin Epigenetics. 2023;15:24. https:\/\/doi.org\/10.1186\/s13148-023-01440-w.","journal-title":"Clin Epigenetics"},{"key":"861_CR21","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ygyno.2013.12.024","volume":"132","author":"SN Akers","year":"2014","unstructured":"Akers SN, Moysich K, Zhang W, Collamat Lai G, Miller A, Lele S, et al. LINE1 and Alu repetitive element DNA methylation in tumors and white blood cells from epithelial ovarian cancer patients. Gynecol Oncol. 2014;132:462\u20137. https:\/\/doi.org\/10.1016\/j.ygyno.2013.12.024.","journal-title":"Gynecol Oncol"},{"key":"861_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/IGC.0000000000000021","volume":"24","author":"A Senthong","year":"2014","unstructured":"Senthong A, Kitkumthorn N, Rattanatanyong P, Khemapech N, Triratanachart S, Mutirangura A. Differences in LINE-1 methylation between endometriotic ovarian cyst and endometriosis-associated ovarian cancer. Int J Gynecol Cancer. 2014;24:36\u201342. https:\/\/doi.org\/10.1097\/IGC.0000000000000021.","journal-title":"Int J Gynecol Cancer"},{"key":"861_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030764","author":"W Zhang","year":"2020","unstructured":"Zhang W, Klinkebiel D, Barger CJ, Pandey S, Guda C, Miller A, et al. Global DNA hypomethylation in epithelial ovarian cancer: passive demethylation and association with genomic instability. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12030764.","journal-title":"Cancers (Basel)."},{"key":"861_CR24","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1525-1438.2007.01117.x","volume":"18","author":"J Pattamadilok","year":"2008","unstructured":"Pattamadilok J, Huapai N, Rattanatanyong P, Vasurattana A, Triratanachat S, Tresukosol D, et al. LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer. Int J Gynecol Cancer. 2008;18:711\u20137. https:\/\/doi.org\/10.1111\/j.1525-1438.2007.01117.x.","journal-title":"Int J Gynecol Cancer"},{"key":"861_CR25","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1158\/1078-0432.CCR-24-2669","volume":"31","author":"M Michel","year":"2025","unstructured":"Michel M, Heidary M, Mechri A, Da Silva K, Gorse M, Dixon V, et al. Noninvasive Multicancer Detection Using DNA Hypomethylation of LINE-1 Retrotransposons. Clin Cancer Res. 2025;31:1275\u201391. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-2669.","journal-title":"Clin Cancer Res"},{"key":"861_CR26","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrg2640","volume":"10","author":"R Cordaux","year":"2009","unstructured":"Cordaux R, Batzer MA. The impact of retrotransposons on human genome evolution. Nat Rev Genet. 2009;10:691\u2013703. https:\/\/doi.org\/10.1038\/nrg2640.","journal-title":"Nat Rev Genet"},{"key":"861_CR27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1101\/gad.351979.124","volume":"39","author":"L Ataei","year":"2025","unstructured":"Ataei L, Zhang J, Monis S, Giemza K, Mittal K, Yang J, et al. LINE1 elements at distal junctions of rDNA repeats regulate nucleolar organization in human embryonic stem cells. Genes Dev. 2025;39:280\u201398. https:\/\/doi.org\/10.1101\/gad.351979.124.","journal-title":"Genes Dev"},{"key":"861_CR28","doi-asserted-by":"publisher","first-page":"6718","DOI":"10.1128\/mcb.10.12.6718-6729.1990","volume":"10","author":"GD Swergold","year":"1990","unstructured":"Swergold GD. Identification, characterization, and cell specificity of a human LINE-1 promoter. Mol Cell Biol. 1990;10:6718\u201329. https:\/\/doi.org\/10.1128\/mcb.10.12.6718-6729.1990.","journal-title":"Mol Cell Biol"},{"key":"861_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/s0378-1119(96)00856-6","volume":"189","author":"K Hata","year":"1997","unstructured":"Hata K, Sakaki Y. Identification of critical CpG sites for repression of L1 transcription by DNA methylation. Gene. 1997;189:227\u201334. https:\/\/doi.org\/10.1016\/s0378-1119(96)00856-6.","journal-title":"Gene"},{"key":"861_CR30","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1093\/nar\/29.21.4493","volume":"29","author":"F Yu","year":"2001","unstructured":"Yu F, Zingler N, Schumann G, Stratling WH. Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription. Nucleic Acids Res. 2001;29:4493\u2013501. https:\/\/doi.org\/10.1093\/nar\/29.21.4493.","journal-title":"Nucleic Acids Res"},{"key":"861_CR31","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1093\/nar\/gkg663","volume":"31","author":"N Yang","year":"2003","unstructured":"Yang N, Zhang L, Zhang Y, Kazazian HH Jr. An important role for RUNX3 in human L1 transcription and retrotransposition. Nucleic Acids Res. 2003;31:4929\u201340. https:\/\/doi.org\/10.1093\/nar\/gkg663.","journal-title":"Nucleic Acids Res"},{"key":"861_CR32","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1093\/nar\/gkh698","volume":"32","author":"JN Athanikar","year":"2004","unstructured":"Athanikar JN, Badge RM, Moran JV. A YY1-binding site is required for accurate human LINE-1 transcription initiation. Nucleic Acids Res. 2004;32:3846\u201355. https:\/\/doi.org\/10.1093\/nar\/gkh698.","journal-title":"Nucleic Acids Res"},{"key":"861_CR33","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/nar\/28.2.411","volume":"28","author":"T Tchenio","year":"2000","unstructured":"Tchenio T, Casella JF, Heidmann T. Members of the SRY family regulate the human LINE retrotransposons. Nucleic Acids Res. 2000;28:411\u20135. https:\/\/doi.org\/10.1093\/nar\/28.2.411.","journal-title":"Nucleic Acids Res"},{"key":"861_CR34","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jmb.2005.03.003","volume":"348","author":"SL Martin","year":"2005","unstructured":"Martin SL, Cruceanu M, Branciforte D, Wai-Lun Li P, Kwok SC, Hodges RS, et al. LINE-1 retrotransposition requires the nucleic acid chaperone activity of the ORF1 protein. J Mol Biol. 2005;348:549\u201361. https:\/\/doi.org\/10.1016\/j.jmb.2005.03.003.","journal-title":"J Mol Biol"},{"key":"861_CR35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/s0092-8674(00)81997-2","volume":"87","author":"Q Feng","year":"1996","unstructured":"Feng Q, Moran JV, Kazazian HH Jr, Boeke JD. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell. 1996;87:905\u201316. https:\/\/doi.org\/10.1016\/s0092-8674(00)81997-2.","journal-title":"Cell"},{"key":"861_CR36","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1126\/science.1722352","volume":"254","author":"SL Mathias","year":"1991","unstructured":"Mathias SL, Scott AF, Kazazian HH Jr, Boeke JD, Gabriel A. Reverse transcriptase encoded by a human transposable element. Science. 1991;254:1808\u201310. https:\/\/doi.org\/10.1126\/science.1722352.","journal-title":"Science"},{"key":"861_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/science.ads8412","volume":"388","author":"GE Ghanim","year":"2025","unstructured":"Ghanim GE, Hu H, Boulanger J, Nguyen THD. Structural mechanism of LINE-1 target-primed reverse transcription. Science. 2025;388:eads8412. https:\/\/doi.org\/10.1126\/science.ads8412.","journal-title":"Science"},{"key":"861_CR38","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.1093\/emboj\/cdf592","volume":"21","author":"GJ Cost","year":"2002","unstructured":"Cost GJ, Feng Q, Jacquier A, Boeke JD. Human L1 element target-primed reverse transcription in vitro. EMBO J. 2002;21:5899\u2013910. https:\/\/doi.org\/10.1093\/emboj\/cdf592.","journal-title":"EMBO J"},{"key":"861_CR39","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1101\/gad.351051.123","volume":"37","author":"C Mendez-Dorantes","year":"2023","unstructured":"Mendez-Dorantes C, Burns KH. LINE-1 retrotransposition and its deregulation in cancers: implications for therapeutic opportunities. Genes Dev. 2023;37:948\u201367. https:\/\/doi.org\/10.1101\/gad.351051.123.","journal-title":"Genes Dev"},{"key":"861_CR40","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.molcel.2015.10.012","volume":"60","author":"AJ Doucet","year":"2015","unstructured":"Doucet AJ, Wilusz JE, Miyoshi T, Liu Y, Moran JV. A 3\u2019 Poly(A) tract is required for LINE-1 retrotransposition. Mol Cell. 2015;60:728\u201341. https:\/\/doi.org\/10.1016\/j.molcel.2015.10.012.","journal-title":"Mol Cell"},{"key":"861_CR41","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.1073\/pnas.0831042100","volume":"100","author":"B Brouha","year":"2003","unstructured":"Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV, et al. Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci U S A. 2003;100:5280\u20135. https:\/\/doi.org\/10.1073\/pnas.0831042100.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"861_CR42","doi-asserted-by":"publisher","first-page":"MDNA3-0061-2014","DOI":"10.1128\/microbiolspec.MDNA3-0061-2014","volume":"3","author":"SR Richardson","year":"2015","unstructured":"Richardson SR, Doucet AJ, Kopera HC, Moldovan JB, Garcia-Perez JL, Moran JV. The influence of LINE-1 and SINE retrotransposons on mammalian genomes. Microbiol Spectr. 2015;3:MDNA3-0061\u20132014. https:\/\/doi.org\/10.1128\/microbiolspec.MDNA3-0061-2014.","journal-title":"Microbiol Spectr."},{"key":"861_CR43","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00018-024-05195-2","volume":"81","author":"M Lee Jr","year":"2024","unstructured":"Lee M Jr, Ahmad SF, Xu J. Regulation and function of transposable elements in cancer genomes. Cell Mol Life Sci. 2024;81:157. https:\/\/doi.org\/10.1007\/s00018-024-05195-2.","journal-title":"Cell Mol Life Sci"},{"key":"861_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/genetics\/iyaf202","author":"HL Levin","year":"2025","unstructured":"Levin HL, Lee S, Anand A. The 5\u2019 truncation of retrotransposon L1: a process of genome integrity. Genetics. 2025. https:\/\/doi.org\/10.1093\/genetics\/iyaf202.","journal-title":"Genetics"},{"key":"861_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2024.100498","volume":"4","author":"S Lanciano","year":"2024","unstructured":"Lanciano S, Philippe C, Sarkar A, Pratella D, Domrane C, Doucet AJ, et al. Locus-level L1 DNA methylation profiling reveals the epigenetic and transcriptional interplay between L1s and their integration sites. Cell Genom. 2024;4:100498. https:\/\/doi.org\/10.1016\/j.xgen.2024.100498.","journal-title":"Cell Genom."},{"key":"861_CR46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrg2337","volume":"9","author":"C Feschotte","year":"2008","unstructured":"Feschotte C. Transposable elements and the evolution of regulatory networks. Nat Rev Genet. 2008;9:397\u2013405. https:\/\/doi.org\/10.1038\/nrg2337.","journal-title":"Nat Rev Genet"},{"key":"861_CR47","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/1471-2164-8-392","volume":"8","author":"T Zemojtel","year":"2007","unstructured":"Zemojtel T, Penzkofer T, Schultz J, Dandekar T, Badge R, Vingron M. Exonization of active mouse L1s: a driver of transcriptome evolution? BMC Genomics. 2007;8:392. https:\/\/doi.org\/10.1186\/1471-2164-8-392.","journal-title":"BMC Genomics"},{"key":"861_CR48","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1093\/nar\/gku1394","volume":"43","author":"M Startek","year":"2015","unstructured":"Startek M, Szafranski P, Gambin T, Campbell IM, Hixson P, Shaw CA, et al. Genome-wide analyses of LINE-LINE-mediated nonallelic homologous recombination. Nucleic Acids Res. 2015;43:2188\u201398. https:\/\/doi.org\/10.1093\/nar\/gku1394.","journal-title":"Nucleic Acids Res"},{"key":"861_CR49","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1016\/j.cell.2022.04.017","volume":"185","author":"D Porubsky","year":"2022","unstructured":"Porubsky D, Hops W, Ashraf H, Hsieh P, Rodriguez-Martin B, Yilmaz F, et al. Recurrent inversion polymorphisms in humans associate with genetic instability and genomic disorders. Cell. 2022;185:1986-2005e26. https:\/\/doi.org\/10.1016\/j.cell.2022.04.017.","journal-title":"Cell"},{"key":"861_CR50","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.12975","author":"EN Elliott","year":"2016","unstructured":"Elliott EN, Sheaffer KL, Kaestner KH. The \u201cde novo\u201d DNA methyltransferase Dnmt3b compensates the Dnmt1-deficient intestinal epithelium. Elife. 2016. https:\/\/doi.org\/10.7554\/eLife.12975.","journal-title":"Elife"},{"key":"861_CR51","doi-asserted-by":"publisher","first-page":"105003","DOI":"10.1016\/j.isci.2022.105003","volume":"25","author":"Y Liu","year":"2022","unstructured":"Liu Y, Xu Z, Shi J, Zhang Y, Yang S, Chen Q, et al. DNA methyltransferases are complementary in maintaining DNA methylation in embryonic stem cells. iScience. 2022;25:105003. https:\/\/doi.org\/10.1016\/j.isci.2022.105003.","journal-title":"iScience."},{"key":"861_CR52","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1038\/s41467-020-16919-w","volume":"11","author":"T Dahlet","year":"2020","unstructured":"Dahlet T, Argueso Lleida A, Al Adhami H, Dumas M, Bender A, Ngondo RP, et al. Genome-wide analysis in the mouse embryo reveals the importance of DNA methylation for transcription integrity. Nat Commun. 2020;11:3153. https:\/\/doi.org\/10.1038\/s41467-020-16919-w.","journal-title":"Nat Commun"},{"key":"861_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13072-023-00519-1","volume":"16","author":"H Luo","year":"2023","unstructured":"Luo H, Wu X, Zhu XH, Yi X, Du D, Jiang DS. The functions of SET domain bifurcated histone lysine methyltransferase 1 (SETDB1) in biological process and disease. Epigenet Chromatin. 2023;16:47. https:\/\/doi.org\/10.1186\/s13072-023-00519-1.","journal-title":"Epigenet Chromatin"},{"key":"861_CR54","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkag100","author":"O Karlsson","year":"2026","unstructured":"Karlsson O, Pandiloski N, Horvath V, Adami A, Garza R, Johansson PA, et al. Loss of SETDB1-mediated H3K9me3 in human neural progenitor cells leads to transcriptional activation of L1 retrotransposons. Nucleic Acids Res. 2026. https:\/\/doi.org\/10.1093\/nar\/gkag100.","journal-title":"Nucleic Acids Res"},{"key":"861_CR55","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.11418","author":"M Walter","year":"2016","unstructured":"Walter M, Teissandier A, Perez-Palacios R, Bourc\u2019his D. An epigenetic switch ensures transposon repression upon dynamic loss of DNA methylation in embryonic stem cells. Elife. 2016. https:\/\/doi.org\/10.7554\/eLife.11418.","journal-title":"Elife"},{"key":"861_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/v12060596","author":"K Fukuda","year":"2020","unstructured":"Fukuda K, Shinkai Y. SETDB1-mediated silencing of retroelements. Viruses. 2020. https:\/\/doi.org\/10.3390\/v12060596.","journal-title":"Viruses"},{"key":"861_CR57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nature04917","volume":"442","author":"A Girard","year":"2006","unstructured":"Girard A, Sachidanandam R, Hannon GJ, Carmell MA. A germline-specific class of small RNAs binds mammalian Piwi proteins. Nature. 2006;442:199\u2013202. https:\/\/doi.org\/10.1038\/nature04917.","journal-title":"Nature"},{"key":"861_CR58","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1261\/rna.079349.122","volume":"29","author":"M Dowling","year":"2023","unstructured":"Dowling M, Homolka D, Raad N, Gos P, Pandey RR, Pillai RS. In vivo PIWI slicing in mouse testes deviates from rules established in vitro. RNA. 2023;29:308\u201316. https:\/\/doi.org\/10.1261\/rna.079349.122.","journal-title":"RNA"},{"key":"861_CR59","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1016\/j.celrep.2016.08.027","volume":"16","author":"K Kojima-Kita","year":"2016","unstructured":"Kojima-Kita K, Kuramochi-Miyagawa S, Nagamori I, Ogonuki N, Ogura A, Hasuwa H, et al. MIWI2 as an Effector of DNA Methylation and Gene Silencing in Embryonic Male Germ Cells. Cell Rep. 2016;16:2819\u201328. https:\/\/doi.org\/10.1016\/j.celrep.2016.08.027.","journal-title":"Cell Rep"},{"key":"861_CR60","doi-asserted-by":"publisher","unstructured":"Fabry MH, Ciabrelli F, Munafo M, Eastwood EL, Kneuss E, Falciatori I, et al. piRNA-guided co-transcriptional silencing coopts nuclear export factors. Elife. 2019; 8: p. https:\/\/doi.org\/10.7554\/eLife.47999.","DOI":"10.7554\/eLife.47999"},{"key":"861_CR61","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1093\/nar\/gkm181","volume":"35","author":"M Kinomoto","year":"2007","unstructured":"Kinomoto M, Kanno T, Shimura M, Ishizaka Y, Kojima A, Kurata T, et al. All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res. 2007;35:2955\u201364. https:\/\/doi.org\/10.1093\/nar\/gkm181.","journal-title":"Nucleic Acids Res"},{"key":"861_CR62","doi-asserted-by":"publisher","first-page":"22161","DOI":"10.1074\/jbc.M601716200","volume":"281","author":"H Muckenfuss","year":"2006","unstructured":"Muckenfuss H, Hamdorf M, Held U, Perkovic M, Lower J, Cichutek K, et al. APOBEC3 proteins inhibit human LINE-1 retrotransposition. J Biol Chem. 2006;281:22161\u201372. https:\/\/doi.org\/10.1074\/jbc.M601716200.","journal-title":"J Biol Chem"},{"key":"861_CR63","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1128\/mcb.11.2.886-893.1991","volume":"11","author":"K Mooslehner","year":"1991","unstructured":"Mooslehner K, Muller U, Karls U, Hamann L, Harbers K. Structure and expression of a gene encoding a putative GTP-binding protein identified by provirus integration in a transgenic mouse strain. Mol Cell Biol. 1991;11:886\u201393. https:\/\/doi.org\/10.1128\/mcb.11.2.886-893.1991.","journal-title":"Mol Cell Biol"},{"key":"861_CR64","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1742-4690-9-53","volume":"9","author":"S Arjan-Odedra","year":"2012","unstructured":"Arjan-Odedra S, Swanson CM, Sherer NM, Wolinsky SM, Malim MH. Endogenous MOV10 inhibits the retrotransposition of endogenous retroelements but not the replication of exogenous retroviruses. Retrovirology. 2012;9:53. https:\/\/doi.org\/10.1186\/1742-4690-9-53.","journal-title":"Retrovirology"},{"key":"861_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002941","volume":"8","author":"JL Goodier","year":"2012","unstructured":"Goodier JL, Cheung LE, Kazazian HH Jr. MOV10 RNA helicase is a potent inhibitor of retrotransposition in cells. PLoS Genet. 2012;8:e1002941. https:\/\/doi.org\/10.1371\/journal.pgen.1002941.","journal-title":"PLoS Genet"},{"key":"861_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000869","volume":"6","author":"AC Groner","year":"2010","unstructured":"Groner AC, Meylan S, Ciuffi A, Zangger N, Ambrosini G, Denervaud N, et al. KRAB-zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading. PLoS Genet. 2010;6:e1000869. https:\/\/doi.org\/10.1371\/journal.pgen.1000869.","journal-title":"PLoS Genet"},{"key":"861_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015082","volume":"5","author":"S Frietze","year":"2010","unstructured":"Frietze S, O\u2019Geen H, Blahnik KR, Jin VX, Farnham PJ. ZNF274 recruits the histone methyltransferase SETDB1 to the 3\u2019 ends of ZNF genes. PLoS ONE. 2010;5:e15082. https:\/\/doi.org\/10.1371\/journal.pone.0015082.","journal-title":"PLoS ONE"},{"key":"861_CR68","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature13760","volume":"516","author":"FM Jacobs","year":"2014","unstructured":"Jacobs FM, Greenberg D, Nguyen N, Haeussler M, Ewing AD, Katzman S, et al. An evolutionary arms race between KRAB zinc-finger genes ZNF91\/93 and SVA\/L1 retrotransposons. Nature. 2014;516:242\u20135. https:\/\/doi.org\/10.1038\/nature13760.","journal-title":"Nature"},{"key":"861_CR69","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/cas.16007","volume":"115","author":"Y Baba","year":"2024","unstructured":"Baba Y, Yasuda N, Bundo M, Nakachi Y, Ueda J, Ishimoto T, et al. LINE-1 hypomethylation, increased retrotransposition and tumor-specific insertion in upper gastrointestinal cancer. Cancer Sci. 2024;115:247\u201356. https:\/\/doi.org\/10.1111\/cas.16007.","journal-title":"Cancer Sci"},{"key":"861_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13100-019-0191-2","volume":"11","author":"D Ardeljan","year":"2020","unstructured":"Ardeljan D, Wang X, Oghbaie M, Taylor MS, Husband D, Deshpande V, et al. LINE-1 ORF2p expression is nearly imperceptible in human cancers. Mob DNA. 2020;11:1. https:\/\/doi.org\/10.1186\/s13100-019-0191-2.","journal-title":"Mob DNA"},{"key":"861_CR71","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41586-025-09825-y","volume":"650","author":"T Zhang","year":"2026","unstructured":"Zhang T, Zhao W, Wirth C, Diaz-Gay M, Yin J, Cecati M, et al. Uncovering the role of LINE-1 in the evolution of lung adenocarcinoma. Nature. 2026;650:230\u201341. https:\/\/doi.org\/10.1038\/s41586-025-09825-y.","journal-title":"Nature"},{"key":"861_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/genes15020143","author":"KJ Kines","year":"2024","unstructured":"Kines KJ, Sokolowski M, DeFreece C, Shareef A, deHaro DL, Belancio VP. Large deletions, cleavage of the telomeric repeat sequence, and reverse transcriptase-mediated DNA damage response associated with long interspersed element-1 ORF2p enzymatic activities. Genes (Basel). 2024. https:\/\/doi.org\/10.3390\/genes15020143.","journal-title":"Genes (Basel)."},{"key":"861_CR73","doi-asserted-by":"publisher","DOI":"10.1101\/2024.12.14.628481","author":"C Mendez-Dorantes","year":"2024","unstructured":"Mendez-Dorantes C, Zeng X, Karlow JA, Schofield P, Turner S, Kalinowski J, et al. Chromosomal rearrangements and instability caused by the LINE-1 retrotransposon. bioRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.12.14.628481.","journal-title":"bioRxiv."},{"key":"861_CR74","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1261\/rna.078721.121","volume":"27","author":"A Gazquez-Gutierrez","year":"2021","unstructured":"Gazquez-Gutierrez A, Witteveldt J, Heras SR, Macias S. Sensing of transposable elements by the antiviral innate immune system. RNA. 2021;27:735\u201352. https:\/\/doi.org\/10.1261\/rna.078721.121.","journal-title":"RNA"},{"key":"861_CR75","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1158\/2159-8290.CD-24-1317","volume":"15","author":"E You","year":"2025","unstructured":"You E, Patel BK, Rojas AS, Sun S, Danaher P, Ho NI, et al. LINE-1 ORF1p mimics viral innate immune evasion mechanisms in pancreatic ductal adenocarcinoma. Cancer Discov. 2025;15:1063\u201382. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-1317.","journal-title":"Cancer Discov"},{"key":"861_CR76","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3389\/fcell.2020.00657","volume":"8","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhang R, Yu J. New understanding of the relevant role of LINE-1 retrotransposition in human disease and immune modulation. Front Cell Dev Biol. 2020;8:657. https:\/\/doi.org\/10.3389\/fcell.2020.00657.","journal-title":"Front Cell Dev Biol."},{"key":"861_CR77","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1222077","volume":"337","author":"E Lee","year":"2012","unstructured":"Lee E, Iskow R, Yang L, Gokcumen O, Haseley P, Luquette LJ 3rd, et al. Landscape of somatic retrotransposition in human cancers. Science. 2012;337:967\u201371. https:\/\/doi.org\/10.1126\/science.1222077.","journal-title":"Science"},{"key":"861_CR78","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1177\/15353702211031247","volume":"246","author":"KS Ramos","year":"2021","unstructured":"Ramos KS, Bojang P, Bowers E. Role of long interspersed nuclear element-1 in the regulation of chromatin landscapes and genome dynamics. Exp Biol Med (Maywood). 2021;246:2082\u201397. https:\/\/doi.org\/10.1177\/15353702211031247.","journal-title":"Exp Biol Med (Maywood)"},{"key":"861_CR79","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1101\/gr.231837.117","volume":"28","author":"H Jung","year":"2018","unstructured":"Jung H, Choi JK, Lee EA. Immune signatures correlate with L1 retrotransposition in gastrointestinal cancers. Genome Res. 2018;28:1136\u201346. https:\/\/doi.org\/10.1101\/gr.231837.117.","journal-title":"Genome Res"},{"key":"861_CR80","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0784-9","volume":"566","author":"M De Cecco","year":"2019","unstructured":"De Cecco M, Ito T, Petrashen AP, Elias AE, Skvir NJ, Criscione SW, et al. L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature. 2019;566:73\u20138. https:\/\/doi.org\/10.1038\/s41586-018-0784-9.","journal-title":"Nature"},{"key":"861_CR81","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.18632\/oncotarget.27673","volume":"11","author":"BYD Hoong","year":"2020","unstructured":"Hoong BYD, Gan YH, Liu H, Chen ES. cGAS-STING pathway in oncogenesis and cancer therapeutics. Oncotarget. 2020;11:2930\u201355. https:\/\/doi.org\/10.18632\/oncotarget.27673.","journal-title":"Oncotarget"},{"key":"861_CR82","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.immuni.2020.05.013","volume":"53","author":"X Zhang","year":"2020","unstructured":"Zhang X, Bai XC, Chen ZJ. Structures and Mechanisms in the cGAS-STING Innate Immunity Pathway. Immunity. 2020;53:43\u201353. https:\/\/doi.org\/10.1016\/j.immuni.2020.05.013.","journal-title":"Immunity"},{"key":"861_CR83","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1038\/s44319-025-00551-0","volume":"26","author":"Y Huang","year":"2025","unstructured":"Huang Y, Xu F, Wang L, Mei S, Zhao F, Wang L, et al. STING inhibits LINE-1 retrotransposition through sorting ORF1p to lysosomes for degradation. EMBO Rep. 2025;26:4607\u201330. https:\/\/doi.org\/10.1038\/s44319-025-00551-0.","journal-title":"EMBO Rep"},{"key":"861_CR84","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41588-019-0562-0","volume":"52","author":"B Rodriguez-Martin","year":"2020","unstructured":"Rodriguez-Martin B, Alvarez EG, Baez-Ortega A, Zamora J, Supek F, Demeulemeester J, et al. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. Nat Genet. 2020;52:306\u201319. https:\/\/doi.org\/10.1038\/s41588-019-0562-0.","journal-title":"Nat Genet"},{"key":"861_CR85","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1038\/s41467-019-11770-0","volume":"10","author":"T Cajuso","year":"2019","unstructured":"Cajuso T, Sulo P, Tanskanen T, Katainen R, Taira A, Hanninen UA, et al. Retrotransposon insertions can initiate colorectal cancer and are associated with poor survival. Nat Commun. 2019;10:4022. https:\/\/doi.org\/10.1038\/s41467-019-11770-0.","journal-title":"Nat Commun"},{"key":"861_CR86","doi-asserted-by":"publisher","first-page":"32215","DOI":"10.1073\/pnas.2019450117","volume":"117","author":"K Yamaguchi","year":"2020","unstructured":"Yamaguchi K, Soares AO, Goff LA, Talasila A, Choi JA, Ivenitsky D, et al. Striking heterogeneity of somatic L1 retrotransposition in single normal and cancerous gastrointestinal cells. Proc Natl Acad Sci U S A. 2020;117:32215\u201322. https:\/\/doi.org\/10.1073\/pnas.2019450117.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"861_CR87","doi-asserted-by":"publisher","first-page":"588","DOI":"10.2174\/1566524015666150831130827","volume":"15","author":"D Rangasamy","year":"2015","unstructured":"Rangasamy D, Lenka N, Ohms S, Dahlstrom JE, Blackburn AC, Board PG. Activation of LINE-1 Retrotransposon Increases the Risk of Epithelial-Mesenchymal Transition and Metastasis in Epithelial Cancer. Curr Mol Med. 2015;15:588\u201397. https:\/\/doi.org\/10.2174\/1566524015666150831130827.","journal-title":"Curr Mol Med"},{"key":"861_CR88","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12943-022-01618-5","volume":"21","author":"Z Sun","year":"2022","unstructured":"Sun Z, Zhang R, Zhang X, Sun Y, Liu P, Francoeur N, et al. LINE-1 promotes tumorigenicity and exacerbates tumor progression via stimulating metabolism reprogramming in non-small cell lung cancer. Mol Cancer. 2022;21:147. https:\/\/doi.org\/10.1186\/s12943-022-01618-5.","journal-title":"Mol Cancer"},{"key":"861_CR89","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12864-016-2800-5","volume":"17","author":"SW Criscione","year":"2016","unstructured":"Criscione SW, Theodosakis N, Micevic G, Cornish TC, Burns KH, Neretti N, et al. Genome-wide characterization of human L1 antisense promoter-driven transcripts. BMC Genomics. 2016;17:463. https:\/\/doi.org\/10.1186\/s12864-016-2800-5.","journal-title":"BMC Genomics"},{"key":"861_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2019.11.004","volume":"241","author":"A Cervantes-Ayalc","year":"2020","unstructured":"Cervantes-Ayalc A, Ruiz Esparza-Garrido R, Velazquez-Flores MA. Long Interspersed Nuclear Elements 1 (LINE1): The chimeric transcript L1-MET and its involvement in cancer. Cancer Genet. 2020;241:1\u201311. https:\/\/doi.org\/10.1016\/j.cancergen.2019.11.004.","journal-title":"Cancer Genet"},{"key":"861_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314610","author":"P Lavia","year":"2022","unstructured":"Lavia P, Sciamanna I, Spadafora C. An epigenetic LINE-1-based mechanism in cancer. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232314610.","journal-title":"Int J Mol Sci"},{"key":"861_CR92","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.137569","author":"AA de Cubas","year":"2020","unstructured":"de Cubas AA, Dunker W, Zaninovich A, Hongo RA, Bhatia A, Panda A, et al. DNA hypomethylation promotes transposable element expression and activation of immune signaling in renal cell cancer. JCI Insight. 2020. https:\/\/doi.org\/10.1172\/jci.insight.137569.","journal-title":"JCI Insight."},{"key":"861_CR93","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.molcel.2012.06.010","volume":"47","author":"T Chandra","year":"2012","unstructured":"Chandra T, Kirschner K, Thuret JY, Pope BD, Ryba T, Newman S, et al. Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation. Mol Cell. 2012;47:203\u201314. https:\/\/doi.org\/10.1016\/j.molcel.2012.06.010.","journal-title":"Mol Cell"},{"key":"861_CR94","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1101\/gad.12.5.599","volume":"12","author":"K Struhl","year":"1998","unstructured":"Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 1998;12:599\u2013606. https:\/\/doi.org\/10.1101\/gad.12.5.599.","journal-title":"Genes Dev"},{"key":"861_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/mog2.59","volume":"3","author":"L Tao","year":"2024","unstructured":"Tao L, Zhou Y, Luo Y, Qiu J, Xiao Y, Zou J, et al. Epigenetic regulation in cancer therapy: From mechanisms to clinical advances. 2024;3:e59. https:\/\/doi.org\/10.1002\/mog2.59.","journal-title":"Epigenetic regulation in cancer therapy: From mechanisms to clinical advances."},{"key":"861_CR96","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.67776","volume":"16","author":"VD Elango","year":"2024","unstructured":"Elango VD, Mugundan UM, Mg R. Efavirenz: New Hope in Cancer Therapy. Cureus. 2024;16:e67776. https:\/\/doi.org\/10.7759\/cureus.67776.","journal-title":"Cureus."},{"key":"861_CR97","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1097\/PGP.0000000000000908","volume":"41","author":"CB Gilks","year":"2022","unstructured":"Gilks CB, Selinger CI, Davidson B, Kobel M, Ledermann JA, Lim D, et al. Data Set for the Reporting of Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Recommendations From the International Collaboration on Cancer Reporting (ICCR). Int J Gynecol Pathol. 2022;41:S119\u201342. https:\/\/doi.org\/10.1097\/PGP.0000000000000908.","journal-title":"Int J Gynecol Pathol"},{"key":"861_CR98","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research N","year":"2011","unstructured":"Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609\u201315. https:\/\/doi.org\/10.1038\/nature10166.","journal-title":"Nature"},{"key":"861_CR99","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ygyno.2019.07.012","volume":"154","author":"P Cybulska","year":"2019","unstructured":"Cybulska P, Paula ADC, Tseng J, Leitao MM Jr, Bashashati A, Huntsman DG, et al. Molecular profiling and molecular classification of endometrioid ovarian carcinomas. Gynecol Oncol. 2019;154:516\u201323. https:\/\/doi.org\/10.1016\/j.ygyno.2019.07.012.","journal-title":"Gynecol Oncol"},{"key":"861_CR100","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/s41598-023-28840-5","volume":"13","author":"S Sato","year":"2023","unstructured":"Sato S, Gillette M, de Santiago PR, Kuhn E, Burgess M, Doucette K, et al. LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma. Sci Rep. 2023;13:1537. https:\/\/doi.org\/10.1038\/s41598-023-28840-5.","journal-title":"Sci Rep"},{"key":"861_CR101","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.humpath.2019.06.001","volume":"92","author":"Z Xia","year":"2019","unstructured":"Xia Z, Cochrane DR, Tessier-Cloutier B, Leung S, Karnezis AN, Cheng AS, et al. Expression of L1 retrotransposon open reading frame protein 1 in gynecologic cancers. Hum Pathol. 2019;92:39\u201347. https:\/\/doi.org\/10.1016\/j.humpath.2019.06.001.","journal-title":"Hum Pathol"},{"key":"861_CR102","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1158\/1078-0432.CCR-10-2315","volume":"17","author":"A Woloszynska-Read","year":"2011","unstructured":"Woloszynska-Read A, Zhang W, Yu J, Link PA, Mhawech-Fauceglia P, Collamat G, et al. Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS\/CTCF expression ratio and advanced stage. Clin Cancer Res. 2011;17:2170\u201380. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-2315.","journal-title":"Clin Cancer Res"},{"key":"861_CR103","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41698-025-00849-1","volume":"9","author":"PR de Santiago","year":"2025","unstructured":"de Santiago PR, Sato S, Zhang SJ, Dougher MC, Devins KM, Bilecz AJ, et al. LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarker. NPJ Precis Oncol. 2025;9:62. https:\/\/doi.org\/10.1038\/s41698-025-00849-1.","journal-title":"NPJ Precis Oncol."},{"key":"861_CR104","doi-asserted-by":"publisher","first-page":"1598868","DOI":"10.3389\/fonc.2025.1598868","volume":"15","author":"XQ Tan","year":"2025","unstructured":"Tan XQ, Guo AY, Zheng LF, Xiong J. Research progress on FOXM1 in ovarian cancer diagnosis and therapeutics. Front Oncol. 2025;15:1598868. https:\/\/doi.org\/10.3389\/fonc.2025.1598868.","journal-title":"Front Oncol"},{"key":"861_CR105","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ajpath.2018.11.005","volume":"189","author":"TR Pisanic 2nd","year":"2019","unstructured":"Pisanic TR 2nd, Asaka S, Lin SF, Yen TT, Sun H, Bahadirli-Talbott A, et al. Long interspersed nuclear element 1 retrotransposons become deregulated during the development of ovarian cancer precursor lesions. Am J Pathol. 2019;189:513\u201320. https:\/\/doi.org\/10.1016\/j.ajpath.2018.11.005.","journal-title":"Am J Pathol"},{"key":"861_CR106","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1101\/gad.266098.115","volume":"30","author":"A Wylie","year":"2016","unstructured":"Wylie A, Jones AE, D\u2019Brot A, Lu WJ, Kurtz P, Moran JV, et al. p53 genes function to restrain mobile elements. Genes Dev. 2016;30:64\u201377. https:\/\/doi.org\/10.1101\/gad.266098.115.","journal-title":"Genes Dev"},{"key":"861_CR107","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.ajpath.2014.01.007","volume":"184","author":"N Rodic","year":"2014","unstructured":"Rodic N, Sharma R, Sharma R, Zampella J, Dai L, Taylor MS, et al. Long interspersed element-1 protein expression is a hallmark of many human cancers. Am J Pathol. 2014;184:1280\u20136. https:\/\/doi.org\/10.1016\/j.ajpath.2014.01.007.","journal-title":"Am J Pathol"},{"key":"861_CR108","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2409447121","volume":"121","author":"G Zhang","year":"2024","unstructured":"Zhang G, Xiang M, Gu L, Zhou J, Zhang B, Tian W, et al. The essential role of TTC28 in maintaining chromosomal stability via HSPA8 chaperone-mediated autophagy. Proc Natl Acad Sci U S A. 2024;121:e2409447121. https:\/\/doi.org\/10.1073\/pnas.2409447121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"861_CR109","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2115999119","author":"W McKerrow","year":"2022","unstructured":"McKerrow W, Wang X, Mendez-Dorantes C, Mita P, Cao S, Grivainis M, et al. LINE-1 expression in cancer correlates with p53 mutation, copy number alteration, and S phase checkpoint. Proc Natl Acad Sci U S A. 2022. https:\/\/doi.org\/10.1073\/pnas.2115999119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"861_CR110","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071802","volume":"8","author":"KM Kuusisto","year":"2013","unstructured":"Kuusisto KM, Akinrinade O, Vihinen M, Kankuri-Tammilehto M, Laasanen SL, Schleutker J. copy number variation analysis in familial BRCA1\/2-negative Finnish breast and ovarian cancer. PLoS ONE. 2013;8:e71802. https:\/\/doi.org\/10.1371\/journal.pone.0071802.","journal-title":"PLoS ONE"},{"key":"861_CR111","doi-asserted-by":"publisher","first-page":"E9942","DOI":"10.1073\/pnas.1707658114","volume":"114","author":"H Schuster","year":"2017","unstructured":"Schuster H, Peper JK, Bosmuller HC, Rohle K, Backert L, Bilich T, et al. The immunopeptidomic landscape of ovarian carcinomas. Proc Natl Acad Sci U S A. 2017;114:E9942\u201351. https:\/\/doi.org\/10.1073\/pnas.1707658114.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"861_CR112","doi-asserted-by":"publisher","first-page":"zcaa040","DOI":"10.1093\/narcan\/zcaa040","volume":"3","author":"M Alkailani","year":"2021","unstructured":"Alkailani M, Palidwor G, Poulin A, Mohan R, Pepin D, Vanderhyden B, et al. A genome-wide strategy to identify causes and consequences of retrotransposon expression finds activation by BRCA1 in ovarian cancer. NAR Cancer. 2021;3:zcaa040. https:\/\/doi.org\/10.1093\/narcan\/zcaa040.","journal-title":"NAR Cancer."},{"key":"861_CR113","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13073-024-01413-5","volume":"16","author":"A Barnicle","year":"2024","unstructured":"Barnicle A, Ray-Coquard I, Rouleau E, Cadoo K, Simpkins F, Aghajanian C, et al. Patterns of genomic instability in > 2000 patients with ovarian cancer across six clinical trials evaluating olaparib. Genome Med. 2024;16:145. https:\/\/doi.org\/10.1186\/s13073-024-01413-5.","journal-title":"Genome Med."},{"key":"861_CR114","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41594-020-0374-z","volume":"27","author":"P Mita","year":"2020","unstructured":"Mita P, Sun X, Fenyo D, Kahler DJ, Li D, Agmon N, et al. BRCA1 and S phase DNA repair pathways restrict LINE-1 retrotransposition in human cells. Nat Struct Mol Biol. 2020;27:179\u201391. https:\/\/doi.org\/10.1038\/s41594-020-0374-z.","journal-title":"Nat Struct Mol Biol"},{"key":"861_CR115","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1016\/j.celrep.2018.05.090","volume":"23","author":"THM Nguyen","year":"2018","unstructured":"Nguyen THM, Carreira PE, Sanchez-Luque FJ, Schauer SN, Fagg AC, Richardson SR, et al. L1 retrotransposon heterogeneity in ovarian tumor cell evolution. Cell Rep. 2018;23:3730\u201340. https:\/\/doi.org\/10.1016\/j.celrep.2018.05.090.","journal-title":"Cell Rep"},{"key":"861_CR116","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djq127","volume":"102","author":"G Liu","year":"2010","unstructured":"Liu G, Yang G, Chang B, Mercado-Uribe I, Huang M, Zheng J, et al. Stanniocalcin 1 and ovarian tumorigenesis. J Natl Cancer Inst. 2010;102:812\u201327. https:\/\/doi.org\/10.1093\/jnci\/djq127.","journal-title":"J Natl Cancer Inst"},{"key":"861_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26188862","author":"D Tierno","year":"2025","unstructured":"Tierno D, Pavan N, Giudici F, Grassi G, Valeri E, Zanconati F, et al. LINE-1 266\/97 and ALU 260\/111 copy number ratios in circulating cell-free DNA in plasma as potential biomarkers for the detection of prostate cancer: a pilot case-control study. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26188862.","journal-title":"Int J Mol Sci"},{"key":"861_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146657","author":"S Fumarola","year":"2025","unstructured":"Fumarola S, Cecati M, Marchegiani F, Francini E, Maniscalco R, Sabbatinelli J, et al. Repeatome analysis of plasma circulating DNA in patients with cardiovascular disease: variation with cell-free DNA integrity\/length and clinical parameters. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26146657.","journal-title":"Int J Mol Sci"},{"key":"861_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2025.e00754","volume":"22","author":"AI Giannopoulou","year":"2025","unstructured":"Giannopoulou AI, Skouras P, Sarantis P, Armoundas A, Palamaris K, Gargalionis AN, et al. LINE-1 hypomethylation in cell-free DNA of high-grade glioma patients correlates with tissue levels and is associated with reduced DNMT1 and H4K20me3 expression. Neurotherapeutics. 2025;22:e00754. https:\/\/doi.org\/10.1016\/j.neurot.2025.e00754.","journal-title":"Neurotherapeutics"},{"key":"861_CR120","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1158\/1078-0432.CCR-24-4051","volume":"31","author":"JJ Szymanski","year":"2025","unstructured":"Szymanski JJ, Chauhan PS, Chaudhuri AA. LINE-1 Retrotransposons as Cell-free DNA Biomarkers for Multicancer Early Detection. Clin Cancer Res. 2025;31:1179\u201381. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-4051.","journal-title":"Clin Cancer Res"},{"key":"861_CR121","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13148-022-01285-9","volume":"14","author":"H Lu","year":"2022","unstructured":"Lu H, Liu Y, Wang J, Fu S, Wang L, Huang C, et al. Detection of ovarian cancer using plasma cell-free DNA methylomes. Clin Epigenetics. 2022;14:74. https:\/\/doi.org\/10.1186\/s13148-022-01285-9.","journal-title":"Clin Epigenetics"},{"key":"861_CR122","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41586-018-0703-0","volume":"563","author":"SY Shen","year":"2018","unstructured":"Shen SY, Singhania R, Fehringer G, Chakravarthy A, Roehrl MHA, Chadwick D, et al. Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature. 2018;563:579\u201383. https:\/\/doi.org\/10.1038\/s41586-018-0703-0.","journal-title":"Nature"},{"key":"861_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104222","volume":"83","author":"L Liang","year":"2022","unstructured":"Liang L, Zhang Y, Li C, Liao Y, Wang G, Xu J, et al. Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer. EBioMedicine. 2022;83:104222. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104222.","journal-title":"EBioMedicine"},{"key":"861_CR124","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/978-1-0716-2883-6_10","volume":"2607","author":"A Sarkar","year":"2023","unstructured":"Sarkar A, Lanciano S, Cristofari G. Targeted nanopore resequencing and methylation analysis of LINE-1 retrotransposons. Methods Mol Biol. 2023;2607:173\u201398. https:\/\/doi.org\/10.1007\/978-1-0716-2883-6_10.","journal-title":"Methods Mol Biol"},{"key":"861_CR125","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3233\/CBM-191018","volume":"28","author":"S Stamenkovic","year":"2020","unstructured":"Stamenkovic S, Cheng J, Surowy H, Burwinkel B, Gundert M. Circulating cell-free DNA variables as marker of ovarian cancer patients: A pilot study. Cancer Biomark. 2020;28:159\u201367. https:\/\/doi.org\/10.3233\/CBM-191018.","journal-title":"Cancer Biomark"},{"key":"861_CR126","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1158\/2159-8290.CD-23-0313","volume":"13","author":"MS Taylor","year":"2023","unstructured":"Taylor MS, Wu C, Fridy PC, Zhang SJ, Senussi Y, Wolters JC, et al. Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multicancer biomarker. Cancer Discov. 2023;13:2532\u201347. https:\/\/doi.org\/10.1158\/2159-8290.CD-23-0313.","journal-title":"Cancer Discov"},{"key":"861_CR127","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1158\/1078-0432.CCR-17-3055","volume":"24","author":"D Matei","year":"2018","unstructured":"Matei D, Ghamande S, Roman L, Alvarez Secord A, Nemunaitis J, Markham MJ, et al. A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses. Clin Cancer Res. 2018;24:2285\u201393. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-3055.","journal-title":"Clin Cancer Res"},{"key":"861_CR128","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ijc.23849","volume":"124","author":"A Daskalos","year":"2009","unstructured":"Daskalos A, Nikolaidis G, Xinarianos G, Savvari P, Cassidy A, Zakopoulou R, et al. Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int J Cancer. 2009;124:81\u20137. https:\/\/doi.org\/10.1002\/ijc.23849.","journal-title":"Int J Cancer"},{"key":"861_CR129","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2147\/LCTT.S11726","volume":"1","author":"AN Nguyen","year":"2010","unstructured":"Nguyen AN, Hollenbach PW, Richard N, Luna-Moran A, Brady H, Heise C, et al. Azacitidine and decitabine have different mechanisms of action in non-small cell lung cancer cell lines. Lung Cancer (Auckl). 2010;1:119\u201340. https:\/\/doi.org\/10.2147\/LCTT.S11726.","journal-title":"Lung Cancer (Auckl)."},{"key":"861_CR130","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1182\/blood-2007-07-103960","volume":"111","author":"Y Oki","year":"2008","unstructured":"Oki Y, Jelinek J, Shen L, Kantarjian HM, Issa JP. Induction of hypomethylation and molecular response after decitabine therapy in patients with chronic myelomonocytic leukemia. Blood. 2008;111:2382\u20134. https:\/\/doi.org\/10.1182\/blood-2007-07-103960.","journal-title":"Blood"},{"key":"861_CR131","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/01635581.2019.1577981","volume":"71","author":"LS Rozek","year":"2019","unstructured":"Rozek LS, Virani S, Bellile EL, Taylor JMG, Sartor MA, Zarins KR, et al. Soy Isoflavone Supplementation Increases Long Interspersed Nucleotide Element-1 (LINE-1) Methylation in Head and Neck Squamous Cell Carcinoma. Nutr Cancer. 2019;71:772\u201380. https:\/\/doi.org\/10.1080\/01635581.2019.1577981.","journal-title":"Nutr Cancer"},{"key":"861_CR132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250157","volume":"16","author":"L Szabo","year":"2021","unstructured":"Szabo L, Molnar R, Tomesz A, Deutsch A, Darago R, Nowrasteh G, et al. The effects of flavonoids, green tea polyphenols and coffee on DMBA induced LINE-1 DNA hypomethylation. PLoS ONE. 2021;16:e0250157. https:\/\/doi.org\/10.1371\/journal.pone.0250157.","journal-title":"PLoS ONE"},{"key":"861_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19072118","author":"A Maugeri","year":"2018","unstructured":"Maugeri A, Barchitta M, Mazzone MG, Giuliano F, Basile G, Agodi A. Resveratrol modulates SIRT1 and DNMT functions and restores LINE-1 methylation levels in ARPE-19 cells under oxidative stress and inflammation. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19072118.","journal-title":"Int J Mol Sci"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-026-00861-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-026-00861-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-026-00861-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T19:02:44Z","timestamp":1787425364000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-026-00861-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":133,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["861"],"URL":"https:\/\/doi.org\/10.1007\/s40291-026-00861-6","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors received no specific funding for this study.","order":1,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nicoletta Bonci, Valentina Schiavoni, Jesmina Rexha, Alice Romagnoli, Roberto Campagna, and Giovanni Tossetta declare that they have no conflicts of interest that might be relevant to the contents of this article.","order":2,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm contribution to the paper as follows: Methodology, software, resources, data curation, writing \u2013 original draft preparation: Nicoletta Bonci and Valentina Schiavoni; writing \u2013 review and editing, visualization: Nicoletta Bonci, Valentina Schiavoni, Jesmina Rexha, Alice Romagnoli, Giovanni Tossetta, and Roberto Campagna; supervision, project administration, conceptualization: Giovanni Tossetta and Roberto Campagna. All authors have read and approved the final version.","order":3,"name":"Ethics","label":"Authors\u2019 Contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analyzed during the study.","order":4,"name":"Ethics","label":"Data Availability Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Consent (participation and publication):Consent (participation and publication)","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":7,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}}]}}